✨ Health and Tax Notices




14 JULY 2011 NEW ZEALAND GAZETTE, No. 105


New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland

Product: Diovan
Active Ingredient: Valsartan 160mg
Dosage Form: Film coated tablet

New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland

Product: Diovan
Active Ingredient: Valsartan 320mg
Dosage Form: Film coated tablet

Dated this 7th day of July 2011.

STEWART JESSAMINE, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001.

go4708


Inland Revenue

Income Tax Act 2007

Resident Withholding Tax on Interest

Cancelled certificates of exemption for the period 01/04/11 to 30/06/11

[table of cancelled RWT certificate numbers omitted]

Resident Withholding Tax on Interest

Reissued certificates of exemption for the period 01/04/11 to 30/06/11

[table of reissued RWT certificate numbers omitted]

go4727



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2011, No 105





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
7 July 2011
Medicines Act, New Medicines, Valsartan, Diovan, Novartis
  • STEWART JESSAMINE, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

πŸ’° Cancelled Certificates of Exemption for Resident Withholding Tax on Interest

πŸ’° Finance & Revenue
Income Tax Act 2007, Resident Withholding Tax, Certificates of Exemption, Cancellation

πŸ’° Reissued Certificates of Exemption for Resident Withholding Tax on Interest

πŸ’° Finance & Revenue
Income Tax Act 2007, Resident Withholding Tax, Certificates of Exemption, Reissue